Experience from a randomized controlled trial with Impella 2.5 versus IABP in STEMI patients with cardiogenic pre-shock.: Lessons learned from the IMPRESS in STEMI trial
Autor: | Ouweneel, D.M., Engstrom, A.E., Sjauw, K.D., Hirsch, A., Hill, J.M., Gockel, B., Tuseth, V., van der Schaaf, R.J., Henriques, J.P.S. |
---|---|
Zdroj: | In International Journal of Cardiology 1 January 2016 202:894-896 |
Databáze: | ScienceDirect |
Externí odkaz: |